Literature DB >> 33834553

A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR-Light-Triggered Hyperthermia.

Lingna Wang1,2, Yingjie Yu1,2, Dengshuai Wei1,2, Lingpu Zhang1, Xiaoyan Zhang3, Guanxin Zhang1,2, Dan Ding3, Haihua Xiao1,2, Deqing Zhang1,2.   

Abstract

A systematic combination strategy is proposed for overcoming cisplatin resistance using near-infrared (NIR)-light-triggered hyperthermia. A new photothermal polymer DAP-F is complexed with a reduction-sensitive amphiphilic polymer P1 to form F-NPs with photothermal effect. Subsequently, to build the final nanosystem F-Pt-NPs, F-NPs are combined with Pt-NPs, which are obtained by encapsulating a Pt(IV) prodrug with P1. Mild hyperthermia (43 °C), generated from F-Pt-NPs induced by an 808 nm NIR laser, have various effects such as: i) enhancing the cellular membrane permeability to promote the uptake of drugs; ii) activating cisplatin by accelerating the glutathione consumption; iii) increasing the Pt-DNA adducts formation and possibly the formation of a portion of irreparable Pt-DNA interstrand crosslinks, thereby inhibiting the repair of DNA. In vitro, it is found that even on cisplatin-resistant A549DDP cells, the IC50 of F-Pt-NPs (43 °C) is only 7.0 × 10-6 m Pt mL-1 . In vivo, on a patient-derived xenograft model of multidrug resistant lung cancer, the efficacy of the F-Pt-NPs (43 °C) treatment group shows a tumor inhibition rate of 94%. Taken together, here, an important perspective of resolving cascade drug resistance with the assistance of mild hyperthermia triggered by NIR light is presented, which can be of great significance for clinic translation.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  cascade drug resistance; cisplatin; combination therapy; mild hyperthermia; patient-derived xenograft models

Year:  2021        PMID: 33834553     DOI: 10.1002/adma.202100599

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  6 in total

1.  Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin.

Authors:  Xing Li; Lingpu Zhang; Tuo Li; Shumu Li; Wenjing Wu; Lingyu Zhao; Peng Xie; Jinqi Yang; Peipei Li; Yangyang Zhang; Haihua Xiao; Yingjie Yu; Zhenwen Zhao
Journal:  J Nanobiotechnology       Date:  2022-06-03       Impact factor: 9.429

2.  3D printed hydrogel scaffolds combining glutathione depletion-induced ferroptosis and photothermia-augmented chemodynamic therapy for efficiently inhibiting postoperative tumor recurrence.

Authors:  Wentao Dang; Wei-Chih Chen; Enguo Ju; Yanteng Xu; Kai Li; Haixia Wang; Kun Wang; Shixian Lv; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Nanobiotechnology       Date:  2022-06-07       Impact factor: 9.429

Review 3.  Nanomedicine potentiates mild photothermal therapy for tumor ablation.

Authors:  Zijun Jiang; Tianyi Li; Hao Cheng; Feng Zhang; Xiaoyu Yang; Shihao Wang; Jianping Zhou; Yang Ding
Journal:  Asian J Pharm Sci       Date:  2021-10-15       Impact factor: 6.598

Review 4.  Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer.

Authors:  Chengyuan Zhang; Xuemei Zhou; Hanyi Zhang; Xuanliang Han; Baijun Li; Ran Yang; Xing Zhou
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 5.  Nanomedicines for Overcoming Cancer Drug Resistance.

Authors:  Tingting Hu; Hanlin Gong; Jiayue Xu; Yuan Huang; Fengbo Wu; Zhiyao He
Journal:  Pharmaceutics       Date:  2022-08-01       Impact factor: 6.525

6.  Boosting cisplatin chemotherapy by nanomotor-enhanced tumor penetration and DNA adducts formation.

Authors:  Lihua Xu; Kaixiang Zhang; Xing Ma; Yingying Li; Yajie Jin; Chenglin Liang; Yong Wang; Wendi Duan; Hongling Zhang; Zhenzhong Zhang; Jinjin Shi; Junjie Liu; Yunlong Wang; Wentao Li
Journal:  J Nanobiotechnology       Date:  2022-09-29       Impact factor: 9.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.